# How Secreted-embryo-derived Trypsin Initiates, Maintains and Terminates Ca2+ Signals in Uterine Epithelial Cells

> **NCT04865367** · — · COMPLETED · sponsor: **ART Fertility Clinics LLC** · enrollment: 81 (actual)

## Conditions studied

- Infertility
- Infertility, Female
- Aneuploidy

## Interventions

- **OTHER:** Exposure to culture media

## Key facts

- **NCT ID:** NCT04865367
- **Lead sponsor:** ART Fertility Clinics LLC
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-11-04
- **Primary completion:** 2023-04-16
- **Final completion:** 2023-05-15
- **Target enrollment:** 81 (ACTUAL)
- **Last updated:** 2024-07-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04865367

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04865367, "How Secreted-embryo-derived Trypsin Initiates, Maintains and Terminates Ca2+ Signals in Uterine Epithelial Cells". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT04865367. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*